Moexipril

Overview

Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.

Indication

用于治疗高血压。

Associated Conditions

Hypertension

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions	2009/10/09	NCT00992862	Phase 1	Completed	Paddock Laboratories, Inc.
A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions	2009/10/06	NCT00990301	Phase 1	Completed	Paddock Laboratories, Inc.
Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions	2009/02/03	NCT00834067	Phase 1	Completed	Teva Pharmaceuticals USA
Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions	2009/02/03	NCT00835042	Phase 1	Completed	Teva Pharmaceuticals USA
Moexipril for Primary Biliary Cirrhosis	2008/01/08	NCT00588302	Phase 2	Completed	Mayo Clinic

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Moexipril Hydrochloride	Physicians Total Care, Inc.	54868-5928	ORAL	7.5 mg in 1 1	4/14/2011
Univasc	UCB, Inc.	0091-3707	ORAL	7.5 mg in 1 1	2/23/2016
Univasc	UCB, Inc.	0091-3715	ORAL	15 mg in 1 1	2/23/2016
Moexipril Hydrochloride	Glenmark Pharmaceuticals Inc., USA	68462-209	ORAL	7.5 mg in 1 1	8/18/2021
Moexipril Hydrochloride	Glenmark Pharmaceuticals Inc., USA	68462-208	ORAL	15 mg in 1 1	8/18/2021
Moexipril Hydrochloride	Physicians Total Care, Inc.	54868-4883	ORAL	15 mg in 1 1	4/14/2011

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access